semaglutide and autoimmune Weight loss, disease activity, patient reported outcomes in patients with musculoskeletal and diseases taking weight loss medications: a retrospective cohort study Using GLP-1 Agonists with Biologics
Description
This happens because the medication addresses a biological driverGLP-1 receptor dysfunctionthat often persists after treatment ends
This powerful medication does more than just help you eat less
[DOI] [PubMed] [Google Scholar] 216.Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A
If there is any doubt about the condition of a stored sample, it must not be used
Key genetic variants like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 influence how efficiently your body responds to semaglutide
